Dr. Kai Schulze-Wundling is Co-Founder & Chief Medical Officer of Frieda Health, a CE-marked digital clinic redefining menopause care and the future of women’s longevity. A Cambridge-trained public health scientist (PhD, MPhil) and former researcher at Germany’s Robert Koch Institute, Kai led the development and clinical study of Frieda’s DiGA for menopause—an RCT-validated intervention now preparing for statutory reimbursement in Germany (expected Q1 2026). At the intersection of prevention, digital therapeutics, and real-world evidence, Kai focuses on how physician-supervised, scalable digital care can extend healthspan for millions.